Phase II Trial of Weekly Nanoparticle Albumin-Bound Paclitaxel With Carboplatin and Trastuzumab as First-line Therapy for Women With HER2-Overexpressing Metastatic Breast Cancer

PURPOSE: This multicenter phase II trial evaluated the efficacy and safety of weekly nanoparticle albumin-bound paclitaxel with carboplatin and weekly trastuzumab as first-line therapy for women with HER2-overexpressing metastatic breast cancer (MBC). PATIENTS AND METHODS: We treated 32 patients who...

Full description

Saved in:
Bibliographic Details
Main Authors: Conlin, Alison K., Seidman, Andrew D., Bach, Ariadne, Lake, Diana, Dickler, Maura, D’Andrea, Gabriella, Traina, Tiffany, Danso, Michael, Brufsky, Adam M., Saleh, Mansoor, Clawson, Alicia, Hudis, Clifford A.
Format: Artigo
Language:Inglês
Published: 2010
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC3883128/
https://ncbi.nlm.nih.gov/pubmed/20705560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3816/CBC.2010.n.036
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items